TerminatedPHASE1, PHASE2NCT02975557

Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)

Studying Graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sandeep Jain, MD
Principal Investigator
Sandeep Jain, MD
University of Illinois at Chicago
Intervention
Brimonidine 0.15%(drug)
Enrollment
15 target
Eligibility
18 years · All sexes
Timeline
2016 – 2017

Study locations (2)

Collaborators

Ocugen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02975557 on ClinicalTrials.gov

Other trials for Graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Graft versus host disease →

← Back to all trials